Other languages Todos Medical Ltd.

Equities

TOMDF

IL0011392375

Market Closed - OTC Markets Other stock markets 18:07:29 25/04/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-99.50%

2023	Todos Announces Notice of Allowance from Uspto for Patent Application Covering Use of Compositions in Tollovid?? and Tollovir?? Ingredients	CI
2023	Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Todos Announces Notice of Allowance from Uspto for Patent Application Covering Use of Compositions in Tollovid?? and Tollovir?? Ingredients	30/08/23
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	14/02/23
Todos Medical Ltd. Enters into Exclusive Worldwide Automated Retail Supply Agreement with Smart Automated Retail Network	16/11/22
Todos Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Todos Medical Terminates Tollovid Products License & Distribution Agreement with T-Cell Protect Hellas S.A	10/11/22
Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for Monkeypox PCR Test to US FDA	14/10/22
Todos Medical Announces USPTO Trademark Notice of Allowance for 3Cl Protease Biomarker Diagnostics Tollotest™	27/09/22
Todos Medical Ltd. Enters into $50 Million Contract to Supply Tollovid(TM) and CBD Products to Retail Distributor Company Nerd Hemp	22/09/22
Todos Medical Initiates Validation Plan for PCR-Based Polio Testing at CLIA/Cap Laboratory Provista Diagnostics	14/09/22
Todos Medical, Ltd. Signs to Agreement with Its 3CL Protease Biology Theranostics Partner NLC Pharma, Ltd	12/09/22
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production	31/08/22
Todos Medical Announces Saliva-Only Monkeypox Testing At Clia/Cap Clinical Lab Provista Diagnostics	26/08/22
Todos Medical, Ltd. Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series	25/08/22
Todos Medical, Ltd Initiates MonkeyPox Diagnostic Case Studies After Being Approached by 4 Patients, Including 3 Women	23/08/22
Todos Medical Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22/08/22
Todos Medical Ltd. Completes Trial Design for Tollovid™ Long Covid Clinical Study in Adults	11/08/22
Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels At CLIA/CAP Lab Provista Diagnostics	10/08/22
Todos Medical, Ltd. Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics	08/08/22
Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics	05/08/22
Todos Medical Ltd. Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients	30/06/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Todos Medical Ltd.

Equities

TOMDF

IL0011392375

Other languages

Filters